Evaluation of Risk Factors for Stroke/Embolism and of Complications Due to Anticoagulant Therapy in Atrial Fibrillation
- 1 October 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (10) , 2246-2252
- https://doi.org/10.1161/hs1001.097090
Abstract
Background and Purpose— We sought to assess in outpatients with atrial fibrillation and oral anticoagulation (1) whether the complication rate is influenced by the presence of the risk factors age >65 years, arterial hypertension, diabetes, or previous stroke; (2) whether the complication rate is influenced by the number of additional drugs taken by patients; and (3) whether problems and interventions differ between patients with or without complications. Methods— Clinical characteristics, drugs, problems, interventions, and complications were registered during 2 years. Results— Three hundred sixty patients (mean age, 68 years; 43% female) were observed for 383 patient-years. Patients aged >65 years had more serious, life-threatening, or fatal complications (11% versus 5.3%/100 patient-years; P=0.0428) than younger patients. Patients with diabetes had more life-threatening and fatal complications (2.8% versus 0.6%/100 patient-years; P=0.0354) than patients without. The complication rate did not differ reg...Keywords
This publication has 37 references indexed in Scilit:
- Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial FibrillationCirculation, 2000
- Additional risk factors in atrial fibrillation patients not receiving warfarinAge and Ageing, 1999
- Characteristics of the SAGE Database: A New Resource for Research on Outcomes in Long-Term CareThe Journals of Gerontology: Series A, 1999
- Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, MinnesotaMayo Clinic Proceedings, 1995
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Survey of use of anticoagulation in patients with atrial fibrillation.BMJ, 1993
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatientsJournal of Internal Medicine, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990